Lillian Tugume - Infectious Diseases

Author Information

Lillian Tugume is a researcher affiliated with the Infectious Diseases Institute at Makerere University in Kampala, Uganda. Her work predominantly focuses on infectious diseases, with a particular interest in meningitis and its association with HIV and tuberculosis. Her research aims to improve diagnosis and treatment strategies for these severe infections, which are critical public health concerns in sub-Saharan Africa.

Research Contributions

Dr. Tugume has made significant contributions to the field of infectious diseases, particularly in the study of meningitis related to HIV and tuberculosis. Her research includes exploring novel treatment regimens, such as the use of single-dose liposomal Amphotericin B for cryptococcal meningitis, and the integration of CNS metagenomics for diagnosing tuberculosis meningitis. Her work often involves collaboration on large-scale studies that examine the impact of biological factors on disease outcomes, as well as the evaluation of diagnostic tools like the Xpert MTB/RIF Ultra. Dr. Tugume's research efforts are crucial in advancing the understanding and management of complex infectious diseases in resource-limited settings.

Aliases

Dr. Lillian Tugume is also known by the alias L. Tugume in her publications. Both names are used interchangeably in academic and research contexts.

Publication and Citation Metrics

Metric	Count
Citation Count	982
H-index	18
Paper Count	62

Publications:

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.

DOI: 10.1056/NEJMoa2111904

Year: 2022

Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics

DOI: 10.1038/s41467-022-29353-x

Year: 2022

A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis.

DOI: 10.1089/AID.2020.0202

Year: 2021

Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa.

DOI: 10.1093/mmy/myaa108

Year: 2021

Cerebrospinal Fluid AFB Smear in Adults with Tuberculous Meningitis: A Systematic Review and Diagnostic Test Accuracy Meta-Analysis

DOI: 10.2139/ssrn.3770634

Year: 2021

High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial

DOI: 10.1093/cid/ciab162

Year: 2021

038 Resolving infectious meningitis in uganda with metagenomics and host transcriptomics

DOI: 10.1136/bmjno-2021-anzan.38

Year: 2021

Establishing targets for advanced HIV disease: A call to action

DOI: 10.4102/sajhivmed.v22i1.1266

Year: 2021

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

DOI: 10.1016/S1473-3099(19)30550-X

Year: 2020

Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death

DOI: 10.3390/jcm9030781

Year: 2020

How Does Aspirin Work?

What Role Do Antimicrobial Resistance Play?

What is Hepatitis B?

How Can HIV/AIDS Be Prevented?

How Can Yellow Fever Be Prevented?

Is Fatigue a Long-term Issue in Infectious Diseases?

What Are Parasitic Infections?

What are the Potential Complications of Strep Throat?

What is hygiene and why is it important?

How Can Genomics Improve Diagnostics?

Partnered Content Networks

Relevant Topics